Haldorson A M, Keys T F, Maker M D, Opitz J L
Antimicrob Agents Chemother. 1978 Sep;14(3):368-70. doi: 10.1128/AAC.14.3.368.
This study evaluated weekly urine cultures of patients with neurogenic bladder disease who underwent intermittent urinary catheterization for bladder retraining. One group of 53 patients in 1974 received regular instillations of 0.1% neomycin after each catheterization. A similar group of 55 patients in 1975 did not receive neomycin and constituted a control group. Distribution of age, sex, diagnosis, and duration of bladder retraining was comparable in both groups. Quantitative bacterial colony counts of 10(4) to 10(5) or greater per ml of urine were considered significant. There was no difference in the incidence of bacteriuria between the neomycin-treated group and the control group (53 versus 49%, respectively), and most patients in each group had colony counts >10(5)/ml. Escherichia coli was seen less frequently in neomycin-treated patients (43.4 versus 62.5%), but a greater percentage of infections due to Pseudomonas aeruginosa, group D streptococci, and yeasts was noted in the neomycin-treated group than in the control group (41.5 versus 22.5%).
本研究评估了因膀胱再训练而接受间歇性导尿的神经源性膀胱疾病患者的每周尿培养情况。1974年的一组53例患者在每次导尿后接受0.1%新霉素的常规灌注。1975年一组类似的55例患者未接受新霉素治疗,构成对照组。两组在年龄、性别、诊断及膀胱再训练持续时间的分布上具有可比性。每毫升尿液中细菌菌落计数达到10⁴至10⁵或更高被视为有意义。新霉素治疗组和对照组的菌尿发生率无差异(分别为53%和49%),且每组大多数患者的菌落计数>10⁵/ml。在接受新霉素治疗的患者中,大肠杆菌的出现频率较低(43.4%对62.5%),但新霉素治疗组中由铜绿假单胞菌、D组链球菌和酵母菌引起的感染百分比高于对照组(41.5%对22.5%)。